✦ LIBER ✦

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+progenitor-derived dendritic cells

✍ Scribed by Joseph W. Fay; A. Karolina Palucka; Sophie Paczesny; Madhav Dhodapkar; Dennis A. Johnston; Susan Burkeholder; Hideki Ueno; Jacques Banchereau

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 359 KB
Volume: 55
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-005-0106-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study in melanoma patients of a

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells

✍ Andreas Mackensen; Birgit Herbst; Ji-Li Chen; Gabriele Köhler; Christoph Noppen; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 268 KB 👁 2 views

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that can be used for vaccination purposes, to induce a specific T-cell response in vivo against melanomaassociated antigens. We have shown that the sequential use of early-acting hematopoietic growth factors, stem cell factor, IL

Analysis of T-cell responses in metastat

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

✍ Marieke Griffioen; Martina Borghi; Peter I. Schrier; Susanne Osanto; Dirk Schade 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 213 KB

Spontaneous Proliferation and Type 2 Cyt

Spontaneous Proliferation and Type 2 Cytokine Secretion by CD4+T Cells in Patients with Metastatic Melanoma Vaccinated with Antigen-Pulsed Dendritic Cells

✍ A. Karolina Palucka; John Connolly; Hideki Ueno; John Kohl; Sophie Paczesny; Mad 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 329 KB

A polyclonal anti-vaccine CD4 T cell res

A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells

✍ Yi Zhang; Nicolina Renkvist; Zhaojun Sun; Beatrice Schuler-Thurner; Nicolas Glai 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

A new dendritic cell vaccine generated w

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+T cell responses against NA17-A2 tumor peptide in melanoma patients

✍ Myrto Trakatelli; Michel Toungouz; Didier Blocklet; Ygierne Dodoo; Laurence Gord 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

Identification of GP100-derived, melanom

Identification of GP100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells

✍ Ichiro Kawashima; Van Tsai; Scott Southwood; Kazutoh Takesako; Esteban Celis; Al 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 2 views

The human melanocyte lineage-specific antigen gp100 contains several epitopes recognized by cytotoxic T lymphocytes (CTL). However, most of the epitopes reported to date are HLA-A2.1-restricted. Despite the high frequency of HLA-A2.1 in melanoma patients, effective population coverage requires the i